Prognostic biomarker for biliopancreatic cancer

Developed by: Instituto de Investigación Sanitaria Fundación Jiménez Díaz

Description

Description

Expression of this protein is associated with increased disease-free progression in patients undergoing biliopancreatic surgery independently of the adjuvant treatment administered.

Applications

Specific protein as a prognostic marker in biliopancreatic cancer and/or to predict disease progression following surgical resection.

Protection status

Co-ownership of the invention.

Request for national patent submitted to the Spanish Patent and Trademark Office.

Cooperation requested

Search for licensees for the patent

Search for partners to undertake joint development of the technology

Therapy area

Oncology

Technology Area

Biotechnology and molecular diagnosis

Status:
N/A
Health technology:
N/A